M.W. Encap Overview
- Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
108
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
M.W. Encap General Information
Description
Manufacturer of liquid and semi-solid filled hard capsule pharmaceutical products. The company manufactures pharmaceuticals for oral drug delivery. It provides filling, banding and coating of capsules services.
Contact Information
Website
www.encapdrugdelivery.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Acquirer
Primary Office
- Units Four, Five & Six
- Oakbank Park Way
- Livingston EH53 0TH
- Scotland, United Kingdom
+44 01506 000000
M.W. Encap Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
M.W. Encap Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Manufacturer of liquid and semi-solid filled hard capsule pharmaceutical products. The company manufactures pharmaceutic
Drug Delivery
Livingston, United Kingdom
108
As of 2015
000000000000
000 00
im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000 00000000
Andernach, Germany
0000
As of 0000
000000000000
000000
sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
0000 00000000
Lyon, France
0000
As of 0000
000000000 00
Add Comparison
M.W. Encap Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LTS Lohmann Therapie-Systeme | Private Equity-Backed | Andernach, Germany | 0000 | 000000000000 | ||
| 000000 | Private Equity-Backed | Lyon, France | 0000 | 000000000 00 | ||
| 000000 000 | Corporate Backed or Acquired | Waldstatt, Switzerland | 000000&0 | |||
| 000 0000000 | Private Equity-Backed | Zug, Switzerland | 0000 | 00000000000 | ||
| 00000 00000000000 | Corporation | Atlanta, GA |
M.W. Encap Patents
M.W. Encap Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3098604-A1 | Dosage forms for delivery of medicines to the lower gastrointestinal tract | Pending | 03-May-2018 | 0000000000 | |
| EP-3787606-A1 | Dosage forms for delivery of medicines to the lower gastrointestinal tract | Inactive | 03-May-2018 | 0000000000 | |
| US-20210113479-A1 | Dosage forms for delivery of medicines to the lower gastrointestinal tract | Inactive | 03-May-2018 | 0000000000 | |
| US-20190029966-A1 | Abuse-resistant pharmaceutical formulations | Inactive | 09-Mar-2016 | 0000000000 | 0 |
| CA-3016510-A1 | Abuse-resistant pharmaceutical formulations | Pending | 09-Mar-2016 | A61K9/4866 |
M.W. Encap Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stephen Brown Ph.D | Chief Executive Officer | ||
| Massoud Bakhshaee | Chief Scientific Officer | ||
| David McNab | Director, Finance |
M.W. Encap Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
